Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Journal of Atherosclerosis and Thrombosis|November 27, 2015
Role of LCAT in AtherosclerosisAlice Ossoli, Sara Simonelli, Cecilia Vitali, et al.
Biochemical and Biophysical Research Communications|December 10, 2002
The C-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phospholipid and cholesterol effluxElda Favari, Franco Bernini, Patrizia Tarugi, et al.
Biochimica Et Biophysica Acta|July 29, 2014
HDL and atherosclerosis: Insights from inherited HDL disordersLaura Calabresi, Monica Gomaraschi, Sara Simonelli, et al.
The Biochemical Journal|May 9, 2002
Size is a major determinant of dissociation and denaturation behaviour of reconstituted high-density lipoproteinsElisabetta Gianazza, Ivano Eberini, Cesare R Sirtori, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 17, 2002
Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol effluxMiriam Lee, Laura Calabresi, Giulia Chiesa, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 16, 2002
Elevated soluble cellular adhesion molecules in subjects with low HDL-cholesterolLaura Calabresi, Monica Gomaraschi, Barbara Villa, et al.
The Journal of Biological Chemistry|December 1, 2001
Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanismSara Deakin, Ilia Leviev, Monica Gomaraschi, et al.
Handbook of Experimental Pharmacology|December 20, 2014
Effects of established hypolipidemic drugs on HDL concentration, subclass distribution, and functionMonica Gomaraschi, Maria Pia Adorni, Maciej Banach, et al.
Atherosclerosis|November 18, 2006
Effects of fenofibrate and simvastatin on HDL-related biomarkers in low-HDL patientsGuido Franceschini, Laura Calabresi, Cinzia Colombo, et al.
Pageof 7